Author response for 'A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol'
| Autor: | null Jinjie He, null Yue Liu, null Chengcheng Liu, null Hanguang Hu, null Lifeng Sun, null Dong Xu, null Jun Li, null Junye Wang, null Xiaobing Chen, null Rongbo Lin, null Yi Jiang, null Yanqiao Zhang, null Weisheng Zhang, null Ying Cheng, null Xiaohong Wu, null Mingzhi Fang, null Enxiao Li, null Ye Xu, null Ye Chen, null Jiayi Li, null Yanyan Cui, null Zhanyu Pan, null Songnan Zhang, null Ying Yuan, null Kefeng Ding |
|---|---|
| Rok vydání: | 2022 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|